Publicaciones

Enfermedades de transmisión respiratoria

 

Publicaciones de Gripe y otros virus respiratorios

  1. Jesús Oliva, Concepción Delgado Sanz, Amparo Larrauri and the Spanish Influenza Surveillance System. Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010-2016. 2017. doi: 10.1111/irv.12499
  2. Rondy M, Larrauri A, Casado I, Alfonsi V, Pitigoi D, Launay O, Syrjänen RK, Gefenaite G, Machado A, Vučina VV, Horváth JK, Paradowska-Stankiewicz I, Marbus SD, Gherasim A, Díaz-González JA, Rizzo C, Ivanciuc AE, Galtier F, Ikonen N, Mickiene A, Gomez V, Kurečić Filipović S, Ferenczi A, Korcinska MR, van Gageldonk-Lafeber R, I-MOVE+ hospital working group, Valenciano M. 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project. Euro Surveill. 2017;22(30):pii=30580. DOI: http://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2017.22.30.30580
  3. Melidou A, Broberg E, European region influenza surveillance network. Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for northern hemisphere 2017/18. Vaccine. 2017. 35(37): 4828-35. doi: 10.1016/j.vaccine.2017.07.057.
  4. Rondy M, Launay O, Castilla J, Costanzo S, Puig-Barberà J, Gefenaite G, Larrauri A, Rizzo C, Pitigoi D, Syrjänen RK, Machado A, Kurečić Filipović S, Krisztina Horváth J, Paradowska-Stankiewicz I, Marbus S, InNHOVE/I-MOVE+working group, Moren A. Repeated seasonal influenza vaccination among elderly in Europe: effects on laboratory confirmed hospitalized influenza. Vaccine. 2017; 35(34):4298-4306. doi: 10.1016/j.vaccine.2017.06.088
  5. Bangert M, Gil H, Oliva J, Delgado C, Vega T, De Mateo S, Larrauri A; Epidemiology Working Group of the Spanish Influenza Sentinel Surveillance System. Pilot study to harmonize the reported influenza intensity levels within the Spanish Influenza Sentinel Surveillance System (SISSS) using the Moving Epidemic Method (MEM). Epidemiol Infect. 2017;145(4):715-22. doi: 10.1017/S0950268816002727
  6. Gherasim A, Martínez-Baz I, Castilla J, Pozo F, Larrauri A, the cycEVA working group. Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain. PLoS One. 2017; 12(6): e0179160. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0179160
  7. Vestergaard LS, Nielsen J, Krause TG, Espenhain L, Tersago K, Bustos Sierra N, Denissov G, Innos K, Virtanen MJ, Fouillet A, Lytras T, Paldy A, Bobvos J, Domegan L, O'Donnell J, Scortichini M, de Martino A, England K, Calleja N, van Asten L, Teirlinck AC, Tønnessen R, White RA, P Silva S, Rodrigues AP, Larrauri A, León I, Farah A, Junker C, Sinnathamby M, Pebody RG, Reynolds A, Bishop J, Gross D, Adlhoch C, Penttinen P, Mølbak K. Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017. Euro Surveill. 2017; 22(14):pii=30506. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388126/
  8. Kissling E, Rondy M, I-MOVE/I-MOVE+ study team. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe. Euro Surveill. 2017;22(7):pii=30464. http://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2017.22.7.30464
  9. Gherasim A, Pozo F, de Mateo S, Gamarra IA, García-Cenoz M, Vega T, Martínez E, Giménez J, Castrillejo D, Larrauri A; cycEVA team and the VEVA Working Group. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15. Vaccine. 2016;34(20):2371-7. doi: 10.1016/j.vaccine.2016.03.035.
  10. Kissling E, Nunes B, Robertson C, Valenciano M, Reuss A, Larrauri A, Cohen JM, Oroszi B, Rizzo C, Machado A, Pitigoi D, Domegan L, Paradowska-Stankiewicz I, Buchholz U, Gherasim A, Daviaud I, Horváth JK, Bella A, Lupulescu E, O Donnell J, Korczyńska M, Moren A; I-MOVE case–control study team. I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?. Euro Surveill. 2016; 21(16). http://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2016.21.16.30201
  11. Valenciano M, Kissling E, Reuss A, Rizzo C, Gherasim A, Horváth J, Domegan L, Pitigoi D, Machado A, Paradowska-Stankiewicz I, Bella A, Larrauri A, Ferenczi A, Joan O´Donell, Lazar M, Pechirra P, Korczyńska M, Pozo F, Moren A, on behalf of the I-MOVE multicentre case–control team. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case–Control Study, Europe 2014/15. Euro Surveill. 2016;21(7):pii=30139. http://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2016.21.7.30139
  12. Tjon-Kon-Fat R, Meerhoff T, Nikisins S, Pires J, Pereyaslov D, Gross D, Brown C, WHO European Region Influenza Network. The potential risks and impact of the start of the 2015–2016 influenza season in the WHO European Region: a rapid risk assessment. Influenza and Other Respir Viruses, 2016. 10(4): 236–46. http://onlinelibrary.wiley.com/doi/10.1111/irv.12381/epdf
  13. Broberg E, Melidou A, Prosenc K, Bragstad K, Hungnes O, on behalf of the WHO European Region and the European Influenza Surveillance Network members of the reporting countries. Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe. Euro Surveill. 2016;21(13):pii=30184. http://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2016.21.13.30184
  14. Jiménez Jorge S, Delgado Sanz C, de Mateo S, Pozo F, Casas I, Larrauri A; Sistema de Vigilancia de la Gripe en España (SVGE). Vigilancia del virus respiratorio sincitial en el marco del Sistema de Vigilancia de la Gripe en España, 2006-2014. Enferm Infecc Microbiol Clin. 2016; 34(2):117–20. doi: 10.1016/j.eimc.2014.12.012
  15. Jiménez-Jorge S, de Mateo S, Delgado-Sanz C, Pozo F, Casas I, García-Cenoz M, Castilla J, Rodriguez C, Vega T, Quiñones C, Martínez E, Vanrell JM, Giménez J, Castrillejo D, Altzíbar JM, Carril F, Ramos JM, Serrano MC, Martínez A, Torner N, Pérez E, Gallardo V, Larrauri A, on behalf of the Spanish Influenza Sentinel Surveillance System. Estimating influenza vaccine effectiveness in Spain using sentinel surveillance data. Euro Surveill. 2015;20(28):pii=21187. http://www.eurosurveillance.org/content/10.2807/1560-7917.ES2015.20.28.21187
  16. León-Gómez I, Delgado-Sanz C, Jiménez-Jorge S, Flores V, Simón F, Gómez-Barroso D, Larrauri A, de Mateo Ontañón S. Exceso de mortalidad relacionado con la gripe en España en el invierno de 2012. Gac Sanit 2015;29 (4): 258-65. doi: 10.1016/j.gaceta.2015.01.011
  17. Vega T, Lozano J,  Meerhoff T, Snacken R, Beauté J, Jorgensen P, Ortiz De Lejarazu R, Domegan L, Mossong J, Nielsen J, Born R, Larrauri A, Brown C. Influenza surveillance in Europe. Influenza surveillance in Europe. Comparing intensity levels calculated using the Moving Epidemic Method. Influenza Other Respir Viruses. 2015; 9(5):234-46. doi: 10.1111/irv.12330
  18. Valenciano M, Kissling E, Reuss A, Jiménez-Jorge S, Horváth JK, Donnell JM, Pitigoi D, Machado A, Pozo F, I-MOVE Multicentre Case Control Study Team. The European I-MOVE Multicentre 2013–2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A (H1N1)pdm09 and heterogenous results by country against A(H3N2). Vaccine. 2015; 33(24): 2813–22. doi: 10.1016/j.vaccine.2015.04.012.
  19. Broberg E, Snacken R, Adlhoch C, Beauté J, Galinska M, Pereyaslov D, Brown C, Penttinen P, on behalf of the WHO European Region and the European Influenza Surveillance Network. Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype. Euro Surveill. 2015;20(4):pii=21023. http://www.eurosurveillance.org/content/10.2807/1560-7917.ES2015.20.4.21023
  20. Mølbak K, Espenhain L, Nielsen J, Tersago K, Bossuyt N, Denissov G, Baburin A, Virtanen M, Fouillet A, Sideroglou T, Gkolfinopoulou K, Paldy A, Bobvos J, van Asten L, de Lange M, Nunes B, da Silva S, Larrauri A, Gómez IL, Tsoumanis A, Junker C, Green H, Pebody R, McMenamin J, Reynolds A, Mazick A. Excess mortality among the elderly in European countries, December 2014 to February 2015. Euro Surveill. 2015;20(11):pii=21065. http://www.eurosurveillance.org/content/10.2807/1560-7917.ES2015.20.11.21065
  21. Jiménez-Jorge S, Pozo F, Larrauri A; cycEVA Study Team. Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the last four seasons 2010–2014. Vaccine. 2015; 33(29): 3276–80. doi: 10.1016/j.vaccine.2015.03.051
  22. Beauté J, Zucs P, Korsun N, Bragstad K, Enouf V, Kossyvakis A, Griškevičius A, Olinger CM, Meijer A, Guiomar R, Prosenc K, Staroňová E, Delgado C, Brytting M, Broberg E. Age-specific differences in influenza virus type and subtype distribution in the 2012/2013 season in 12 European countries. Epidemiol Infect. 2015; 143(14): 2950-8. doi:10.1017/S0950268814003422.
  23. Casas I, Larrauri A, Pozo F. Los virus gripales y la efectividad de la vacuna de gripe. 2015. Virología. 18 (3), p.15-16. http://sevirologia.es/media/uploads/SEV18-3-15.pdf